POPS RICHARD F — SEC Form 4 filings

SEC reporting owner CIK 1126490. 15 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-02-12 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Director96 legs · 57,100 sh · $8,157,36719
Alkermes plc. (ALKS)Director and CEO, Alkermes plc, Director620

Form 4 filings — POPS RICHARD F

FiledFormIssuerReported transactionsSource
2026-05-294NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 2,567 (derivative) @ $0EDGAR
2026-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 3,318 @ $0 · Option exercise (M): 3,318 (derivative) @ $0EDGAR
2026-05-184NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $47.89 · Sale (S): 15,000 @ $157.65 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-03-044Alkermes plc. (ALKS)Grant/award (A): 88,843 (derivative) @ $0EDGAR
2026-02-064Alkermes plc. (ALKS)Grant/award (A): 149,580 · Tax withholding (F): 62,230 @ $33.55EDGAR
2025-05-224NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,869 @ $0 · Grant/award (A): 3,318 (derivative) @ $0 · Option exercise (M): 2,869 (derivative) @ $0EDGAR
2025-02-204Alkermes plc. (ALKS)Grant/award (A): 293,921 (derivative) @ $0EDGAR
2025-02-074Alkermes plc. (ALKS)Grant/award (A): 190,640 · Tax withholding (F): 79,925 @ $31.39EDGAR
2024-05-234NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 2,869 (derivative) @ $0EDGAR
2024-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 4,199 @ $0 · Sale (S): 2,100 @ $141.84 · Option exercise (M): 4,199 (derivative) @ $0EDGAR
2024-03-154NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 23,200 @ $42.76 · Sale (S): 23,200 @ $140.33 · Option exercise (M): 23,200 (derivative) @ $42.76EDGAR
2024-03-124NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,700 @ $42.76 · Sale (S): 1,700 @ $140.05 · Option exercise (M): 100 @ $42.76 · Sale (S): 100 @ $140 · Option exercise (M): 1,700 (derivative) @ $42.76 · Option exercise (M): 100 (derivative) @ $42.76EDGAR
2024-02-274Alkermes plc. (ALKS)Other (J): 4,599 (derivative) @ $46.24 · Other (J): 3,999 (derivative) @ $69.83 · Other (J): 5,999 (derivative) @ $31.64 · Other (J): 3,999 (derivative) @ $53.50 · Other (J): 5,899 (derivative) @ $65.94 · Other (J): 2,419 (derivative) @ $31.93 · +6 moreEDGAR
2024-02-224NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $12.98 · Sale (S): 15,000 @ $132.47 · Option exercise (M): 15,000 (derivative) @ $12.98EDGAR
2024-02-124Alkermes plc. (ALKS)Grant/award (A): 218,551 · Tax withholding (F): 91,757 @ $26.77EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1126490 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →